Nordic Pharma Consulting ApS: Financial statements 2018
CVR: 37368598
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 6,963,201 and a net result of DKK 492,599 compared with DKK 785,477 the year before. That is an increase of 16.3% compared with the year before. Equity in the 2018 report amounted to DKK 747,865. The solvency ratio was 32.1%.
- Gross Profit
- DKK 6,963,201
- Profit/Loss
- DKK 492,599
- Equity
- DKK 747,865
- Total Assets
- DKK 2,328,535
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 7 mio. | 493 t. | 748 t. | - |
| 2017 | - | 6 mio. | 785 t. | 855 t. | - |
| 2016 | - | 1.7 mio. | 620 t. | 670 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Nordic Pharma Consulting ApS has published its annual report for 2017. Gross profit came to DKK 5,989,446, and the net result was DKK 785,477.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.